Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-02-21 超超不吵吵来自湖南省

偏重的研究方向：炎症性肠病
经验分享：接受了，投稿历程发出来给大伙参考一下。
Submission history
Publishing and rights
Submission status Date
Submission is in publishing and rights
21 Feb 2024
Peer review
Submission status Date
Submission accepted
21 Feb 2024
Submission under peer review
07 Feb 2024
Submission passed technical check
07 Feb 2024
Amendment received
07 Feb 2024
Revision received
31 Jan 2024
Submission under peer review
24 Jan 2024
Submission passed technical check
24 Jan 2024
Revision received
05 Jan 2024
Submission under peer review
30 Sep 2023
Technical check
Submission status Date
Submission passed technical check
30 Sep 2023
Amendment received
30 Sep 2023
Submission is under technical check
29 Sep 2023
Submission received
Submission status Date
Submission received
29 Sep 2023

12 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-03-01 隔壁王校长来自浙江省

这个杂志的投稿系统是不是出bug了？

78 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-03-05 ms4000000061332234 来自北京

投稿两周了，还在技术审查

27 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-03-05 维新Tuo1887878 来自广西

1

20 0

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-02-26 隔壁王校长来自浙江省

已经一周了，还是Technical check in progress状态，无语

62 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-03-03 吴⭐ 来自陕西省

很好

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-02-24 zll2020 来自四川省

偏重的研究方向：生物信息学
经验分享：#网络药理学#一个审稿人，等待编辑决定中

72 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2024-02-29 ms2000000089409289 来自江西省

Ready to be assigned to an editor这个是啥

70 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2023-11-28 RichArz 来自福建省

审稿速度:4.0 | 投稿命中率:5.0
偏重的研究方向：生物信息学
经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？

100 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2188542, encodeId=ca19218854206, content=偏重的研究方向：炎症性肠病 经验分享：接受了，投稿历程发出来给大伙参考一下。 Submission history Publishing and rights Submission status Date Submission is in publishing and rights 21 Feb 2024 Peer review Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 07 Feb 2024 Submission passed technical check 07 Feb 2024 Amendment received 07 Feb 2024 Revision received 31 Jan 2024 Submission under peer review 24 Jan 2024 Submission passed technical check 24 Jan 2024 Revision received 05 Jan 2024 Submission under peer review 30 Sep 2023 Technical check Submission status Date Submission passed technical check 30 Sep 2023 Amendment received 30 Sep 2023 Submission is under technical check 29 Sep 2023 Submission received Submission status Date Submission received 29 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Wed Feb 21 18:24:57 CST 2024, time=2024-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190481, encodeId=31ff2190481bd, content=这个杂志的投稿系统是不是出bug了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Mar 01 21:13:44 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191178, encodeId=659021911e8b5, content=投稿两周了，还在技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08c19180436, createdName=ms4000000061332234, createdTime=Tue Mar 05 14:51:52 CST 2024, time=2024-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191174, encodeId=7ac921911e455, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Tue Mar 05 14:38:04 CST 2024, time=2024-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189465, encodeId=c2ca218946563, content=已经一周了，还是Technical check in progress状态，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Feb 26 14:28:35 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190804, encodeId=6229219080461, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:42:28 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2171392, encodeId=d29e21e13929d, content=审稿速度:4.0 | 投稿命中率:5.0 偏重的研究方向：生物信息学 经验分享：第一月就收到一个审稿人的意见，一直等另外一个，但历经四个月多，就变成Editor appointed，这是啥操作！有大佬懂吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a834849850, createdName=RichArz, createdTime=Tue Nov 28 07:45:48 CST 2023, time=2023-11-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144759, encodeId=7b9d2144e592a, content=从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00808482305, createdName=ms4000000848690763, createdTime=Mon Jun 26 09:25:22 CST 2023, time=2023-06-26, status=1, ipAttribution=山东省)]

2023-06-26 ms4000000848690763 来自山东省

从 6.13号的Reviewer reports received/Ready for editor's decision状态今天突然变成Editors inviteds是什么情况呢

72 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务